HaroldEdwardBaysMD

Endocrinology • Louisville, KY

Diabetes, Lipid Metabolism

Preventative Cardiology

Join to view full profile

Are you Dr. Bays?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3288 Illinois Ave
Suite 101
Louisville, KY 40213
Phone+1 502-515-6621

Fax+1 502-515-6620

Summary

Dr. Harold Bays, MD is an endocrinologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky.

Education & Training

University of Louisville School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
University of Louisville School of MedicineResidency, Internal Medicine, 1984 - 1987
University of Louisville School of MedicineClass of 1984

Certifications & Licensure

KY State Medical License 1985 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
American Board of Obesity Medicine Obesity Medicine

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology
Fellow (FACC) American College of Cardiology

Clinical Trials

The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
Completed
Phase 2
Diazoxide Choline in Hypertriglyceridemia Start of enrollment: 2008 Jun 01
Completed
Phase 2
Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes Start of enrollment: 2009 Jan 01
Terminated
Not Applicable
A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study Start of enrollment: 2010 Jan 01
Completed
Phase 4
Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale Start of enrollment: 2010 Apr 01
Completed
Phase 4
Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity Start of enrollment: 2009 Jun 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 di...
Elena A Christofides, Orlando Puente, Paul Norwood, Douglas Denham, Hiralal Maheshwari
Diabetes, Obesity & Metabolism. 2024-06-01
Corrigendum to "Obesity pillars roundtable: Body mass index and body composition in black and female individuals. Race-relevant or racist? Sex-relevant or sexist?" [Ob...
Harold Edward Bays, Sylvia Gonsahn-Bollie, Courtney Younglove, Sean Wharton
Obesity Pillars. 2024-06-01
8 citations
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.
Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, Peter P Toth, Ryan T Morgan
Journal of Clinical Lipidology. 2024-04-24

Press Mentions

Harold Bays on How T2DM Interferes with Weight Reduction in ObesityNovember 26th, 2024
Harold Bays on OMA's Clinical Practice Statement on Obesity and Type 2 DiabetesNovember 1st, 2024
89bio to Host Key Opinion Leader Webinar on Severe Hypertriglyceridemia (SHTG)April 26th, 2022
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member